245 related articles for article (PubMed ID: 27509235)
1. Thrombotic Microangiopathy in the Setting of HIV Infection: A Case Report and Review of the Differential Diagnosis and Therapy.
Saab KR; Elhadad S; Copertino D; Laurence J
AIDS Patient Care STDS; 2016 Aug; 30(8):359-64. PubMed ID: 27509235
[TBL] [Abstract][Full Text] [Related]
2. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
Williams LA; Marques MB;
Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
[TBL] [Abstract][Full Text] [Related]
3. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathies.
Rosove MH
Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
[TBL] [Abstract][Full Text] [Related]
5. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy-related thrombotic microangiopathies: Clues from complement biology.
Fakhouri F
Transfus Apher Sci; 2016 Apr; 54(2):199-202. PubMed ID: 27158062
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab.
Pecoraro C; Ferretti AV; Rurali E; Galbusera M; Noris M; Remuzzi G
Am J Kidney Dis; 2015 Dec; 66(6):1067-70. PubMed ID: 26409664
[TBL] [Abstract][Full Text] [Related]
8. The alternative pathway of complement and the thrombotic microangiopathies.
Teoh CW; Riedl M; Licht C
Transfus Apher Sci; 2016 Apr; 54(2):220-31. PubMed ID: 27160864
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
10. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of complement mediated thrombotic microangiopathies.
Cataland SR; Wu HM
Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
14. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy].
Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y
Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956
[TBL] [Abstract][Full Text] [Related]
15. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
Masset C; Dubois B; Rorive G
Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies.
Zini G; De Cristofaro R
Turk J Haematol; 2019 Nov; 36(4):222-229. PubMed ID: 31337190
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.
Masuda E; Fukushima K; Hebisawa Y; Tanaka M; Ohta A; Imamura A
Medicine (Baltimore); 2023 Oct; 102(41):e35469. PubMed ID: 37832064
[TBL] [Abstract][Full Text] [Related]
18. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy syndrome as an AIDS-defining illness: the experience of J. Stroger Hospital of Cook County.
Tamkus D; Jajeh A; Osafo D; Hadad L; Bhanot B; Yogore MG
Clin Adv Hematol Oncol; 2006 Feb; 4(2):145-9. PubMed ID: 16728923
[TBL] [Abstract][Full Text] [Related]
20. [Thrombotic microangiopathies].
Nielsen OJ; Friis-Hansen L
Ugeskr Laeger; 2009 Nov; 171(49):3614-20. PubMed ID: 19954703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
